for Patients or Caregivers
 
 
for Patients or Caregivers- - - - -Understanding Severe Primary IGFD- - - - -Why Increlex is a Breakthrough Therapy- - - - -About Increlex - - - - -Kids Want to Know Q&A- - - - -Full Prescribing Information- - - - -Medical Information- - - - -


for Healthcare Professionalsfor TerciCare Information
About Increlex

For many years, natural growth hormone was the only treatment available for children with short stature. In the 1980s, manmade—or "recombinant"—growth hormone was introduced,4 but that still did not provide a potential answer for children with severe Primary IGFD since their bodies already produced enough growth hormone. Fortunately, researchers began thinking more about the importance of IGF-1 in the growth process and about new ways to replace this important hormone when its missing. The natural outgrowth was manmade IGF-1.


Full Prescribing Information (pdf)

Patient Information Insert (pdf)



4. Isaksson O. GH, IGF-1, and growth. J Pediatr Endocrinol Metab. 2004:17(suppl 4);1321-1326.



Email this page Email the Increlex website to a friend      Print this page Print this page


 
 
Important Safety Information   |   Home   |   Site Map Tercica